2021
DOI: 10.2196/25428
|View full text |Cite
|
Sign up to set email alerts
|

Acceptability of an mHealth App That Provides Harm Reduction Services Among People Who Inject Drugs: Survey Study

Abstract: Background Harm reduction services reduce the negative consequences of drug injection and are often embedded within syringe service programs (SSPs). However, people who inject drugs (PWID) suboptimally engage with such services because of stigma, fear, transportation restrictions, and limited hours of operation. Mobile health (mHealth) apps may provide an opportunity to overcome these barriers and extend the reach of SSPs beyond that of the traditional brick-and-mortar models. … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 44 publications
0
3
0
Order By: Relevance
“…Our study found this to be implemented in the Russian Federation and Ukraine. While use of online approaches to accessing health services is acceptable by some people who inject drugs [ 36 ], particularly young people [ 37 ], studies have highlighted barriers to access experienced by others who have lower levels of access to devices, technology, mobile data, and internet connections [ 38 40 ], especially older people who inject drugs and those who are homeless [ 41 ]. The COVID-19 pandemic further exacerbated these access barriers as many services moved to online health provision [ 42 – 45 ], reducing access for some.…”
Section: Discussionmentioning
confidence: 99%
“…Our study found this to be implemented in the Russian Federation and Ukraine. While use of online approaches to accessing health services is acceptable by some people who inject drugs [ 36 ], particularly young people [ 37 ], studies have highlighted barriers to access experienced by others who have lower levels of access to devices, technology, mobile data, and internet connections [ 38 40 ], especially older people who inject drugs and those who are homeless [ 41 ]. The COVID-19 pandemic further exacerbated these access barriers as many services moved to online health provision [ 42 – 45 ], reducing access for some.…”
Section: Discussionmentioning
confidence: 99%
“…Patients were more likely to attend their telehealth appointments than their in-person appointments, and so can optimize treatment engagement [ 47 ]. However, few telehealth tools are designed specifically for people who inject drugs [ 81 ], and individuals with serious mental illnesses often struggle to connect cognitively and emotionally during telehealth sessions with their counsellor [ 68 ], and there might be also important selection biases when assessing effectiveness because very severe patients might not be able to engage with the IT skills required and platforms used to deliver these interventions making them only fit for those experiencing milder symptoms or the more “functional-end” of the spectrum. Many people with OUD also may not have access to a quiet or private space in which to attend sessions [ 47 ].…”
Section: Clinical Users Of Telepsychiatrymentioning
confidence: 99%
“…Moving forward, four action points have been repeatedly highlighted to ensure a successful transition to telehealth for SUD treatment [ 46 , 72 , 81 , 82 , 85 ]: (1) investing in telehealth infrastructure; (2) training and equipping providers to provide treatment for SUD via telehealth; (3) providing patients with hardware, training in using telehealth services, and social and financial support; and (4) making the temporary changes to telehealth regulations permanent. As telehealth may not be suitable for all medication types for OUD patient, it is recommended that a hybrid care delivery model is developed that can manage both patient and provider needs [ 47 ].…”
Section: Clinical Users Of Telepsychiatrymentioning
confidence: 99%